a Department of Endocrine Surgery , Burgerhospital Frankfurt , Frankfurt, Germany.
b Department of Nuclear Medicine , University Hospital Frankfurt , Frankfurt, Germany.
Int J Hyperthermia. 2018;35(1):216-225. doi: 10.1080/02656736.2018.1489984. Epub 2018 Oct 9.
Comparison between different thermal ablation systems for thyroid nodules regarding their different procedural characteristics such as treatment-time, number of shots and energy transmission in the context of their clinical performance such as complication rate and volume reduction after three months.
A total of 60 patients with 65 nodules underwent thermal ablation of thyroid nodules with either microwave ablation (MWA) (9 male, 15 female and mean age 57 ± 13 years) or radiofrequency ablation (RFA) (12 male, 24 female and mean age 54 ± 12 years).
Mean initial volume (MWA: 23.90 ± 17.35 ml; RFA: 29.44 ± 30.09 ml), energy transmission (MWA: 13.56 ± 10.17 kJ; RFA: 15.12 ± 13.45 kJ), energy transmission per ml (MWA: 0.85 ± 1.01 kJ/ml; RFA: 0.65 ± 0.32 kJ/ml), power (MWA: 22.69 ± 12.32 J/s; RFA: 20.97 ± 7.86 J/s) and duration of ablation (MWA: 618 ± 304 s; RFA: 695 ± 463 s) were not statistically different (p > .05). MWA required significantly less shots (MWA: 3 ± 1; RFA: 6 ± 3) than RFA (p < .05). At three-months follow-up a significant mean nodular volume reduction of 53.54 ± 15.40% after MWA and 51.21 ± 16.58% after RFA (p < .05) was measured. However, mean nodular volume reduction was not significantly different between both systems (p > .05). One patient treated by MWA reported a transient Horner's syndrome, which recovered without any further treatment. Major complications such as nodule rupture, infection or persisting nerve injuries did not occur.
Both systems are suitable to treat thyroid nodules and show no significant difference in the duration of application, energy transmission and volume reduction. However, MWA requires less shots to treat the whole nodule.
比较不同热消融系统治疗甲状腺结节的疗效差异,包括治疗时间、消融次数和能量传输等方面,以及并发症发生率和术后 3 个月体积缩小率等临床疗效差异。
共 60 例 65 个甲状腺结节患者接受了热消融治疗,其中 9 例为男性,15 例为女性,平均年龄 57±13 岁;24 例为男性,12 例为女性,平均年龄 54±12 岁。
初始体积(MWA:23.90±17.35ml;RFA:29.44±30.09ml)、能量传输(MWA:13.56±10.17kJ;RFA:15.12±13.45kJ)、单位体积能量传输(MWA:0.85±1.01kJ/ml;RFA:0.65±0.32kJ/ml)、功率(MWA:22.69±12.32J/s;RFA:20.97±7.86J/s)和消融时间(MWA:618±304s;RFA:695±463s)无统计学差异(p>.05)。MWA 需要的消融次数(MWA:3±1;RFA:6±3)明显少于 RFA(p<.05)。术后 3 个月,MWA 组和 RFA 组的结节体积分别减少了 53.54±15.40%和 51.21±16.58%,差异有统计学意义(p<.05)。但两种方法的结节体积减少率无统计学差异(p>.05)。1 例 MWA 治疗的患者出现短暂性霍纳综合征,未经治疗自行恢复。未发生结节破裂、感染或持续性神经损伤等严重并发症。
两种系统均适用于治疗甲状腺结节,在应用时间、能量传输和体积减少方面无显著差异。然而,MWA 治疗整个结节所需的消融次数更少。